We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mouse Model Study Supports Sexual Transmission of Zikavirus Infection

By LabMedica International staff writers
Posted on 26 Apr 2016
A newly established mouse model, which is expected to accelerate efforts to develop a vaccine to protect against Zikavirus (ZIKV) infection, revealed high levels of the virus in the testes of the animals, a finding that supports the possible sexual transmission of the disease.

Investigators at Washington University School of Medicine (St. More...
Louis, MO, USA) used wild-type (WT) C57BL/6 mice, as well as a large panel of immune-deficient transgenic mice together with several different strains of ZIKV including a contemporary clinical isolate. In this study, the mice were infected via the skin in a manner that mimicked the bite of the mosquito vector of the disease.

The investigators reported in the April 5, 2016, online edition of the journal Cell Host & Microbe that whereas four- to six-week-old WT mice did not develop clinically apparent disease, mice lacking interferon alpha/beta (IFN-alpha/beta) signaling (genetically engineered triple knockout [TKO] mice) succumbed to infection with all the different ZIKV strains. Viral burden analysis revealed that mice lacking the interferon receptor (Ifnar1−/− mutants), but not WT mice, sustained high levels of ZIKV in all tissues tested, including serum, spleen, brain, spinal cord, and testes. The testes of Ifnar1−/− mice had the highest viral loads, which is relevant to the possible sexual transmission of ZIKV.

"Now that we know the mice can be vulnerable to Zika infection, we can use the animals to test vaccines and therapeutics - and some of those studies are already underway - as well as to understand the pathogenesis of the virus," said senior author Dr. Michael Diamond, professor of medicine at Washington University School of Medicine.

"We looked for evidence of Zika in the mouse testes mostly as an afterthought, due to mounting evidence of sexual transmission and were surprised that viral levels were the highest we saw in any tissue," said Dr. Diamond. "We are now doing subsequent tests to determine how long those viral levels are sustained, which could help us estimate the length of time Zika can be transmitted sexually."

Related Links:
Washington University School of Medicine

Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.